The average one-year price target for Adial Pharmaceuticals (NasdaqCM:ADIL) has been revised to $23.80 / share. This is a decrease of 10.26% from the prior estimate of $26.52 dated March 25, 2026. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results